Inspire Medical Systems IncINSP
Price$70.78Intrinsic value$188.40166% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $898.7M+12.0% YoYTTM through 30 Jun 2026
Net Income $135M+152.4% YoYTTM through 30 Jun 2026
Free Cash Flow $117.1MTTM through 30 Jun 2026

Margins

Current
Gross Margin86.5%
EBITDA Margin7.9%
Operating Margin-0.5%
Net Margin15.0%

Returns

16.5%ROE
14.4%ROA
16.5%ROIC

Balance Sheet Health

Debt / Equity0.00x
Current Ratio6.34x
Net Debt-$283.8Mnet cash position
Cash & Equivalents$127.8M

Quality Metrics

Altman Z-Score13.94
Piotroski F-Score8 / 9
FCF Margin13.0%
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $912M
Diluted EPS$4.53TTM
'19'20'21'22'23'24'25
FY2025: $4.89

Dividend

No dividend

Capital Allocation

R&D Spend$99.7M
Capex Intensity4.4%

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.